Use of riluzole oral disintegrating tablets for treating diseases
US-12364687-B2 · Jul 22, 2025 · US
This page is not indexed by search engines while we improve data quality.
Biohaven Therapeutics Ltd patents
Biohaven Therapeutics Ltd holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 4 |
| First publication | Aug 15, 2023 |
| Latest publication | Jul 22, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis
US-12343347-B2 · Jul 1, 2025 · US
Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of salt
US-12297206-B2 · May 13, 2025 · US
Kv7 channel activators compositions and methods of use
US-11724990-B2 · Aug 15, 2023 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Use of riluzole oral disintegrating tablets for treating diseases
US-12364687-B2 · Jul 22, 2025 · US
Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis
US-12343347-B2 · Jul 1, 2025 · US
Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of salt
US-12297206-B2 · May 13, 2025 · US
Kv7 channel activators compositions and methods of use
US-11724990-B2 · Aug 15, 2023 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 2 |
| Cross-Sectional Technologies | 1 |